Kathrin Brenker has not added Biography.
If you are Kathrin Brenker and would like to personalize this page please email our Author Liaison for assistance.
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Autoimmunity Feb, 2013 | Pubmed ID: 23039284
Max-Planck Institute for Immunobiology und Epigenetics
University of Freiburg
Kathrin Brenker1,2,3,
Kerstin Osthof1,4,
Jianying Yang1,3,
Michael Reth1,3,5
1, Max-Planck Institute for Immunobiology und Epigenetics,
2Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg,
3Centre for Biological Signaling Studies, BIOSS, University of Freiburg,
4, Albert-Ludwigs-Universität,
5Institute for Biology III (Mol. Immunology), Albert-Ludwigs-Universität
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved